Fingerprint
Dive into the research topics of 'Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Srdan Verstovsek, Constantine S. Tam, Martha Wadleigh, Lubomir Sokol, Catherine C. Smith, Lynne A. Bui, Chunyan Song, Douglas O. Clary, Patrycja Olszynski, Jorge Cortes, Hagop Kantarjian, Neil P. Shah
Research output: Contribution to journal › Article › peer-review